Cargando…

Can Aging in Place Be Cost Effective? A Systematic Review

PURPOSE OF THE STUDY: To systematically review cost, cost-minimization and cost-effectiveness studies for assisted living technologies (ALTs) that specifically enable older people to ‘age in place’ and highlight what further research is needed to inform decisions regarding aging in place. DESIGN: Pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Graybill, Erin M., McMeekin, Peter, Wildman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109953/
https://www.ncbi.nlm.nih.gov/pubmed/25058505
http://dx.doi.org/10.1371/journal.pone.0102705
_version_ 1782327939013017600
author Graybill, Erin M.
McMeekin, Peter
Wildman, John
author_facet Graybill, Erin M.
McMeekin, Peter
Wildman, John
author_sort Graybill, Erin M.
collection PubMed
description PURPOSE OF THE STUDY: To systematically review cost, cost-minimization and cost-effectiveness studies for assisted living technologies (ALTs) that specifically enable older people to ‘age in place’ and highlight what further research is needed to inform decisions regarding aging in place. DESIGN: People aged 65+ and their live-in carers (where applicable), using an ALT to age in place at home opposed to a community-dwelling arrangement. METHODS: Studies were identified using a predefined search strategy on two key economic and cost evaluation databases NHS EED, HEED. Studies were assessed using methods recommended by the Campbell and Cochrane Economic Methods Group and presented in a narrative synthesis style. RESULTS: Eight eligible studies were identified from North America spread over a diverse geographical range. The majority of studies reported the ALT intervention group as having lower resource use costs than the control group; though the low methodological quality and heterogeneity of the individual costs and outcomes reported across studies must be considered. IMPLICATIONS: The studies suggest that in some cases ALTs may reduce costs, though little data were identified and what there were was of poor quality. Methods to capture quality of life gains were not used, therefore potential effects on health and wellbeing may be missed. Further research is required using newer developments such as the capabilities approach. High quality studies assessing the cost-effectiveness of ALTs for ageing in place are required before robust conclusion on their use can be drawn.
format Online
Article
Text
id pubmed-4109953
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41099532014-07-29 Can Aging in Place Be Cost Effective? A Systematic Review Graybill, Erin M. McMeekin, Peter Wildman, John PLoS One Research Article PURPOSE OF THE STUDY: To systematically review cost, cost-minimization and cost-effectiveness studies for assisted living technologies (ALTs) that specifically enable older people to ‘age in place’ and highlight what further research is needed to inform decisions regarding aging in place. DESIGN: People aged 65+ and their live-in carers (where applicable), using an ALT to age in place at home opposed to a community-dwelling arrangement. METHODS: Studies were identified using a predefined search strategy on two key economic and cost evaluation databases NHS EED, HEED. Studies were assessed using methods recommended by the Campbell and Cochrane Economic Methods Group and presented in a narrative synthesis style. RESULTS: Eight eligible studies were identified from North America spread over a diverse geographical range. The majority of studies reported the ALT intervention group as having lower resource use costs than the control group; though the low methodological quality and heterogeneity of the individual costs and outcomes reported across studies must be considered. IMPLICATIONS: The studies suggest that in some cases ALTs may reduce costs, though little data were identified and what there were was of poor quality. Methods to capture quality of life gains were not used, therefore potential effects on health and wellbeing may be missed. Further research is required using newer developments such as the capabilities approach. High quality studies assessing the cost-effectiveness of ALTs for ageing in place are required before robust conclusion on their use can be drawn. Public Library of Science 2014-07-24 /pmc/articles/PMC4109953/ /pubmed/25058505 http://dx.doi.org/10.1371/journal.pone.0102705 Text en © 2014 Graybill et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Graybill, Erin M.
McMeekin, Peter
Wildman, John
Can Aging in Place Be Cost Effective? A Systematic Review
title Can Aging in Place Be Cost Effective? A Systematic Review
title_full Can Aging in Place Be Cost Effective? A Systematic Review
title_fullStr Can Aging in Place Be Cost Effective? A Systematic Review
title_full_unstemmed Can Aging in Place Be Cost Effective? A Systematic Review
title_short Can Aging in Place Be Cost Effective? A Systematic Review
title_sort can aging in place be cost effective? a systematic review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109953/
https://www.ncbi.nlm.nih.gov/pubmed/25058505
http://dx.doi.org/10.1371/journal.pone.0102705
work_keys_str_mv AT graybillerinm canaginginplacebecosteffectiveasystematicreview
AT mcmeekinpeter canaginginplacebecosteffectiveasystematicreview
AT wildmanjohn canaginginplacebecosteffectiveasystematicreview